Share Price
Ticker: KDEV List: NASDAQ OMX
Volume:
Press Releases
-
2018-04-26
Karolinska Development's Annual General Meeting 2018
-
2018-04-25
Interim Report January - March 2018
-
2018-04-16
Karolinska Development's portfolio company Aprea presents initial results from the ongoing phase Ib/II study with APR-246 and azacitidine for the treatment of Mutant Myelodysplastic Syndromes
News
-
2018-06-17
Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II combination study with APR-246 at hematology congress
-
2018-05-31
Karolinska Development's portfolio company Pharmanest out-licenses Canadian rights for SHACT to Acerus
-
2018-05-21
Karolinska Development's portfolio company Pharmanest appoints new CEO
